Takeda Pharmaceutical Co Ltd (NYSE:TAK)
$ 13.45 -0.11 (-0.81%) Market Cap: 42.99 Bil Enterprise Value: 70.33 Bil PE Ratio: 22.63 PB Ratio: 0.94 GF Score: 79/100

Takeda Pharmaceutical Co Ltd at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2022 / 06:50PM GMT
Release Date Price: $13.72
Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst

We'll get start with our next session. I'm Shinichiro Muraoka of Morgan Stanley Japan Pharmaceutical team. And today, in this session with Takeda Pharmaceutical -- sorry, before starting that. So important disclosures, please see the Morgan Stanley Research Disclosure website at www.morganstanley.com/disclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. So let's start. So today, we are with Andy Plump of -- President of R&D of Takeda; and Costa Saroukos, CFO. Thank you, Andy and Costa for joining us. Thank you.

Questions & Answers

Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst

So let's get start my question first to Costa about earnings for this year, next year and beyond. First, in this year, your last quarter earnings were quite good, not just with currency support, but quite good earnings. Could you -- I believe

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot